Olema Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
&-
Our ID. Let's go ahead and get started. Welcome everybody, to the 42nd Annual JP Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analyst here at JP Morgan. I'm joined by my squad, Priyanka Grover, Laurie. I'll now come to know our next presenting company is Lima and presenting on behalf of the Company, we have CEO change, though.
Sure. Thank you, Anupam. Thank you, everybody, for joining us both some here and on the web. If you're on the web, you missed it. There was no asked atmospheric River this year. There's just a little bit of rain, so it's actually quite nice in San Francisco. Thank you for the time. And obviously, this is our standard forward-looking statement. So I read that it can be context at your leisure.
2023 was an extraordinary year for Lima. We in 2023 demonstrated a unique opportunity to make a huge impact on treatment options for women with ER-positive, HER2-negative breast cancer. And I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
